This Week’s Life Science Headlines

        Litigation
Continue reading...

Newly Released Study Links Glaucoma to Long-Term Use of Oral Contraceptives

Building upon data secured from the Centers for Disease Control and Prevention, an international team of researchers has concluded that women who have used birth control pills on a long-term basis are twice as likely to have glaucoma, a leading cause of blindness in the United States. Glaucoma is caused by increased fluid pressure on the eye, resulting in irreversible damage to the optic nerve. Glaucoma usually affects patients who are middle-aged and older, and has no known cure. Scientists from the University of California,…
Continue reading...

This Week’s Life Science Headlines

        Litigation
Continue reading...

Despite Reported Risks, Side Effects and Threatened Litigation, Crestor Top Selling Drug

According to a report by the research firm IMS Health, (free membership login required) new prescriptions and refills for Crestor, a drug used to lower cholesterol, exceeded all other prescribed drugs in the United States between October 2012 and September 2013. Crestor (rosuvastatin), like Lipitor (atorvastatin) is widely-used to lower cholesterol and belongs  to a family of drugs called “statins.” Among the best-selling drugs in the United States, statins use the liver to block the body’s creation of cholesterol, which is a key contributor…
Continue reading...

This Week’s Life Science Headlines

        Litigation
Continue reading...

This Week’s Life Science Headlines

        Litigation
Continue reading...

Its Flu Season – Remember the National Childhood Vaccine Injury Act

It is getting to be flu season – with the annual barrage of public-service announcements about the importance of getting this year’s flu vaccine.  Vaccines were also in the news recently on reports of a polio outbreak in Syria. Vaccines also end up the subject of lawsuits, including the recent decision from the United States Court of Appeals for the Federal Circuit in Tembenis v. Sec’y Health & Human Servs., (October 28, 2013), available here, which ruled that future lost earnings cannot be awarded…
Continue reading...

The Manufacturer Made Me Do It – One Claim By Negligent Surgeon Survives

California certainly breeds interesting cases. In the Chao case, available here, recently decided by a federal judge in the Southern District of California, the plaintiff was not an injured person. He was an orthopedic surgeon found to be negligent in his treatment of a patient by an arbitration panel, which awarded in excess of $2 million to the patient. The surgery was a hip replacement surgery during which the surgeon lacerated the patient’s femoral artery. Following the award, the orthopedic surgeon brought an indemnity action…
Continue reading...

This Week’s Life Science Headlines

        Litigation
Continue reading...

D.C. Circuit to Determine if FDA can Regulate Stem Cell Treatments

The intersection of what is the practice of medicine and what is a regulated drug or biologic is an interesting place with constitutional and regulatory implications. These issues have come to the forefront in a significant case involving an autologous stem cell procedure used by an orthopedic group in Colorado.  In United States of America v. Regenerative Sciences, LLC, 878 F. Supp. 2d. 248 (D.D.C. 2012), available here,  a D.C. district court judge issued an opinion addressing many of these constitutional and regulatory issues, which…
Continue reading...